Skip to content

Evaluating efficacy of unani formulation in Acne.

A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to Evaluate the Efficacy and Safety of a Unani Pharmacopeial Formulation Marham Hina in the Management of Buthur Labaniyya (Acne Vulgaris). - NA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058541
Enrollment
60
Registered
2023-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Marham Hina: 1.Dose: As per requirement at affected sites 2. Frequency : Twice a day 3. Route of administration : Local Application 4. Total duration : 6 weeks 5. Dosage Form: Marham (O

Sponsors

National Research Institute of Unani Medicine for Skin Disorders
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of any gender in the age group between 12 to 30 years. Participants having any of the following symptoms of Buthur Labaniyya as Comedones, Papules,Pustules ,Nodules, Itching , Erythema. Participants who are willing to participate and comply with the protocol and to sign IEC approved informed consent / assent form.

Exclusion criteria

Exclusion criteria: Participants aged 30 years. Participants with other variants of acne like acne fulminans, acne rosacea, acne necrotica. Participants suffering from other concomitant diseases like vitiligo, dermatophytosis, psoriasis and eczema. Pregnant or Nursing Women.

Design outcomes

Primary

MeasureTime frame
25% Reduction in Global Acne Grading System Score from baseline Timepoint: 6 Weeks

Secondary

MeasureTime frame
1.Reduction in Cooks Acne Grading Scale , Dermatology Life Quality Index , Visual Analogue Scale Score from baseline 2. Improvement in symptoms from baseline Timepoint: 6 Weeks

Countries

India

Contacts

Public ContactDr Khan Shama Rahimullah

National Research Institute of Unani Medicine for Skin Disorders

ccrumnawab@gmail.com8100992044

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026